These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 23568852

  • 1. Modeling trajectories of regional volume loss in progressive supranuclear palsy.
    Josephs KA, Xia R, Mandrekar J, Gunter JL, Senjem ML, Jack CR, Whitwell JL.
    Mov Disord; 2013 Jul; 28(8):1117-24. PubMed ID: 23568852
    [Abstract] [Full Text] [Related]

  • 2. Imaging measures predict progression in progressive supranuclear palsy.
    Whitwell JL, Xu J, Mandrekar J, Gunter JL, Jack CR, Josephs KA.
    Mov Disord; 2012 Dec; 27(14):1801-4. PubMed ID: 22415715
    [Abstract] [Full Text] [Related]

  • 3. Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy.
    Cordato NJ, Duggins AJ, Halliday GM, Morris JG, Pantelis C.
    Brain; 2005 Jun; 128(Pt 6):1259-66. PubMed ID: 15843423
    [Abstract] [Full Text] [Related]

  • 4. Rates of brain atrophy and clinical decline over 6 and 12-month intervals in PSP: determining sample size for treatment trials.
    Whitwell JL, Xu J, Mandrekar JN, Gunter JL, Jack CR, Josephs KA.
    Parkinsonism Relat Disord; 2012 Mar; 18(3):252-6. PubMed ID: 22079523
    [Abstract] [Full Text] [Related]

  • 5. Longitudinal quantitative MRI in multiple system atrophy and progressive supranuclear palsy.
    Reginold W, Lang AE, Marras C, Heyn C, Alharbi M, Mikulis DJ.
    Parkinsonism Relat Disord; 2014 Feb; 20(2):222-5. PubMed ID: 24239142
    [Abstract] [Full Text] [Related]

  • 6. Clinical and cognitive correlations of regional gray matter atrophy in progressive supranuclear palsy.
    Giordano A, Tessitore A, Corbo D, Cirillo G, de Micco R, Russo A, Liguori S, Cirillo M, Esposito F, Tedeschi G.
    Parkinsonism Relat Disord; 2013 Jun; 19(6):590-4. PubMed ID: 23477861
    [Abstract] [Full Text] [Related]

  • 7. Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy.
    Boxer AL, Geschwind MD, Belfor N, Gorno-Tempini ML, Schauer GF, Miller BL, Weiner MW, Rosen HJ.
    Arch Neurol; 2006 Jan; 63(1):81-6. PubMed ID: 16401739
    [Abstract] [Full Text] [Related]

  • 8. The in vivo distribution of brain tissue loss in Richardson's syndrome and PSP-parkinsonism: a VBM-DARTEL study.
    Agosta F, Kostić VS, Galantucci S, Mesaros S, Svetel M, Pagani E, Stefanova E, Filippi M.
    Eur J Neurosci; 2010 Aug; 32(4):640-7. PubMed ID: 20597976
    [Abstract] [Full Text] [Related]

  • 9. Brain iron deposition fingerprints in Parkinson's disease and progressive supranuclear palsy.
    Boelmans K, Holst B, Hackius M, Finsterbusch J, Gerloff C, Fiehler J, Münchau A.
    Mov Disord; 2012 Mar; 27(3):421-7. PubMed ID: 22290788
    [Abstract] [Full Text] [Related]

  • 10. Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy.
    Paviour DC, Thornton JS, Lees AJ, Jäger HR.
    Mov Disord; 2007 Jan; 22(1):68-74. PubMed ID: 17089396
    [Abstract] [Full Text] [Related]

  • 11. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration.
    Gröschel K, Hauser TK, Luft A, Patronas N, Dichgans J, Litvan I, Schulz JB.
    Neuroimage; 2004 Feb; 21(2):714-24. PubMed ID: 14980574
    [Abstract] [Full Text] [Related]

  • 12. Clinical correlates of longitudinal brain atrophy in progressive supranuclear palsy.
    Tsai RM, Lobach I, Bang J, Whitwell JL, Senjem ML, Jack CR, Rosen H, Miller B, Boxer AL, AL-108-231 Investigators.
    Parkinsonism Relat Disord; 2016 Jul; 28():29-35. PubMed ID: 27132501
    [Abstract] [Full Text] [Related]

  • 13. Progressive supranuclear palsy.
    Duvoisin RC, Golbe LI, Lepore FE.
    Can J Neurol Sci; 1987 Aug; 14(3 Suppl):547-54. PubMed ID: 3315157
    [Abstract] [Full Text] [Related]

  • 14. Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease.
    Zanigni S, Calandra-Buonaura G, Manners DN, Testa C, Gibertoni D, Evangelisti S, Sambati L, Guarino M, De Massis P, Gramegna LL, Bianchini C, Rucci P, Cortelli P, Lodi R, Tonon C.
    Neuroimage Clin; 2016 Aug; 11():736-742. PubMed ID: 27330973
    [Abstract] [Full Text] [Related]

  • 15. Magnetic resonance imaging lesion pattern in Guadeloupean parkinsonism is distinct from progressive supranuclear palsy.
    Lehéricy S, Hartmann A, Lannuzel A, Galanaud D, Delmaire C, Bienaimée MJ, Jodoin N, Roze E, Gaymard B, Vidailhet M.
    Brain; 2010 Aug; 133(Pt 8):2410-25. PubMed ID: 20826434
    [Abstract] [Full Text] [Related]

  • 16. Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
    Messina D, Cerasa A, Condino F, Arabia G, Novellino F, Nicoletti G, Salsone M, Morelli M, Lanza PL, Quattrone A.
    Parkinsonism Relat Disord; 2011 Mar; 17(3):172-6. PubMed ID: 21236720
    [Abstract] [Full Text] [Related]

  • 17. New and reliable MRI diagnosis for progressive supranuclear palsy.
    Oba H, Yagishita A, Terada H, Barkovich AJ, Kutomi K, Yamauchi T, Furui S, Shimizu T, Uchigata M, Matsumura K, Sonoo M, Sakai M, Takada K, Harasawa A, Takeshita K, Kohtake H, Tanaka H, Suzuki S.
    Neurology; 2005 Jun 28; 64(12):2050-5. PubMed ID: 15985570
    [Abstract] [Full Text] [Related]

  • 18. Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy.
    Paviour DC, Price SL, Jahanshahi M, Lees AJ, Fox NC.
    Brain; 2006 Apr 28; 129(Pt 4):1040-9. PubMed ID: 16455792
    [Abstract] [Full Text] [Related]

  • 19. Regional brain atrophy in progressive supranuclear palsy and Lewy body disease.
    Cordato NJ, Halliday GM, Harding AJ, Hely MA, Morris JG.
    Ann Neurol; 2000 Jun 28; 47(6):718-28. PubMed ID: 10852537
    [Abstract] [Full Text] [Related]

  • 20. Assessment of midbrain atrophy in patients with progressive supranuclear palsy with routine magnetic resonance imaging.
    Cosottini M, Ceravolo R, Faggioni L, Lazzarotti G, Michelassi MC, Bonuccelli U, Murri L, Bartolozzi C.
    Acta Neurol Scand; 2007 Jul 28; 116(1):37-42. PubMed ID: 17587253
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.